Ovarian Plus: Gynecologic Cancer Prevention News

WE'LL TELL IT LIKE IT IS By Ceil Sinnex Editor & Publisher (with photo of Robert C. Knapp, MD, co-developer of the CA125 test)

AMERICA HAS TURNED ITS BACK ON OVARIAN CANCER Questionnaire for candidates for U.S. House and U.S. Senate, and state legislatures

REFORM PROPOSAL WOULD END NEGLECT OF OVARIAN CANCER Reprinted from Spring 1996 issue by popular request

THINK YOU'RE AT RISK FOR CANCER? PSYCHOSOCIAL GENETICS CAN HELP YOU By Howard J. Allen, PhD, MSW, CSW Gilda Radner Familial Ovarian Cancer Registry

HOW TO FIND A PSYCHOSOCIAL GENETICIST

THANK YOU! To Linda Yarger, Rhonda Oziel, Cindy June & our subscribers in 27 states and four nations

RESEARCH...RESEARCH...RESEARCH! Our most popular feature, newly doubled. Abstracts of recent research on hereditary cancer lawsuits, cholesterol and ovarian cancer, sporadic ovarian tumors, infertility and ovarian and uterine cancer, and much more.

HOW TO USE HEALTH RESEARCH NEWS

INFORMATION/HELP Includes some new resources

ASLEEP IN NEW YORK STATE? Commentary/By Ceil Sinnex

OVARIAN PLUS OPPOSES BRCA1 GENE TESTING Position statement, international involvement in genetic rights movement

MOMENT OF DIAGNOSIS By Nancy Chando, MS Survivor of Ovarian Carcinoma of Low Malignant Potential

A GREAT OPPORTUNITY Subscribe to OVARIAN PLUS by August 15, 1996...and receive the soon-to-be-published book GILDA'S DISEASE, ABSOLUTELY FREE! Details of the Gilda's Special Offer

OVARIAN PLUS MEDICAL ADVISORS We're proud to announce that Robert C. Knapp, MD of Harvard Medical School co-developer of the CA125 test, has joined our medical advisors.

SURVIVOR SEARCH Ovarian Plus subscriber Dorothy Chambers is seeking a survivor of Mixed Mullerian Tumor, diagnosed earlier than May 1994. Please contact her in care of this newsletter, csinnex@hawaii.edu

MISSION: To achieve and sustain a significant reduction in the number of women who die from ovarian cancer and other gynecologic cancers, through education and political awareness.

All rights reserved under international and Pan-American copyright conventions.

Information published in OVARIAN PLUS (TM) is not to be construed as medical or professional advice. Readers should always consult their physicians for advice and treatment. OVARIAN PLUS does not endorse any research results or treatments reported.

Bylined articles represent the views of the authors, not necessarily those of the publisher.

The title OVARIAN PLUS (TM) is a trademark belonging to Ceil Sinnex.

REPRINTS: Reproduction of OVARIAN PLUS without prior written permission is prohibited, except:
Bona fide subscribers may reprint up to 100 words without further permission, if they mail a copy to OVARIAN PLUS and credit the newsletter thus: "Reprinted from OVARIAN PLUS (TM): Gynecologic Cancer prevention Newsletter"; and make every attempt to add the name of the author of the piece.